67 results
8-K
EX-99.1
GRTS
Gritstone Bio Inc
9 May 24
Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates
4:07pm
by the Biomedical Advanced Research and Development Authority [BARDA]2).This decision is expected to increase the regulatory utility of the study … and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under contract
424B5
GRTS
Gritstone Bio Inc
2 Apr 24
Prospectus supplement for primary offering
5:20pm
and commercialization efforts, expanded research and development activities and costs associated with operating as a public company. To raise capital, we may … ;
the timing of commencement of our future nonclinical studies, clinical trials and research and development programs;
our ability to discover, develop
424B5
GRTS
Gritstone Bio Inc
1 Apr 24
Prospectus supplement for primary offering
4:43pm
conducting our planned clinical trials, manufacturing and commercialization efforts, expanded research and development activities and costs associated … of tumors or virally-infected cells;
the timing of commencement of our future nonclinical studies, clinical trials and research and development programs
8-K
EX-99.1
h6gts
5 Mar 24
Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
4:08pm
8-K
qx19sj8q5ine9el77
12 Feb 24
Results of Operations and Financial Condition
7:39am
8-K
EX-99.1
oofbafugmfm u016q
8 Nov 23
Gritstone bio Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
4:06pm
8-K
mtxfnt6pe0hd0f1 1h
27 Sep 23
Entry into a Material Definitive Agreement
4:07pm
8-K
EX-99.1
d9uaoybvake1jeb
27 Sep 23
Entry into a Material Definitive Agreement
4:07pm
8-K
EX-99.1
7bylw5d23tmuqb
9 Aug 23
Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
4:08pm
8-K
EX-99.1
hye njo3bdo
11 May 23
Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates
4:09pm